Derek Elan Stern, a Director, acquired 1,000,000 Common Shares on a direct ownership basis at a price of $0.117 on November 30th, 2022. This represents a $116,800 investment into the company's shares and an account share holdings change of 9.3%.
Cannara Biotech is in the Pharmaceuticals Sub Industry Group under the Healthcare Sector.
Cannara Biotech Inc. is a Canada-based vertically integrated producer of cannabis and cannabis-derivative products for the Quebec and Canadian markets. It operates through its wholly owned subsidiaries, Cannara Biotech (Quebec) Inc. and Cannara Biotech (Valleyfield) Inc. It operates through two segments: Cannabis operations and Real estate operations. Cannabis operations encompass the cultivation, processing and sale of dried cannabis and cannabis derivatives for the Canadian market and other cannabis services. Real estate operations related to the Farnham and Valleyfield building. It owns and operates two Quebec-based facilities spanning over 1,650,000 square feet providing up to 125,000 kilograms of annualized cultivation output. The Company's brands include Tribal, Nugz, and Orchid CBD. Its facilities deliver cannabis from seed to final packaging at affordable retail prices. Its brand Orchid CBD offers terpene-rich, trichome-covered, oversized dried flowers and pre-rolls. Cannara Biotech Inc. (LOVE) has a high amount of executive buying compared to its small-cap peers in the market over the past three months. According to regulatory filings yesterday, one insider has invested a total amount of $116,800.
No Comments